About this item:

71 Views | 19 Downloads

Author Notes:

Dae Hyun Kim, MD, MPH, ScD, Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, 1200 Centre St, Boston, MA 02131. Email: daehyunkim@hsl.harvard.edu

Drs Wei and Sun contributed equally to the work. Dr Kim and Mr Li had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: Kim, Wei, Sun. Acquisition, analysis, or interpretation of data: All authors. Drafting of the manuscript: Kim, Wei. Critical revision of the manuscript for important intellectual content: All authors. Statistical analysis: Li, Bian, Wei, Sun. Obtained funding: Kim. Administrative, technical, or material support: Kim. Supervision: Kim, Sun.

Dr Kim reported providing paid consultative services to Alosa Health. No other disclosures were reported.

Subjects:

Research Funding:

This study was funded by grant R21AG060227 from the National Institute on Aging (Dr Kim).

Keywords:

  • Aged
  • Algorithms
  • Cholinesterase Inhibitors
  • Dementia
  • Donepezil
  • Female
  • Humans
  • Male
  • Nursing Homes
  • Patient Admission
  • Survival Rate
  • Time Factors

Utility of Restricted Mean Survival Time for Analyzing Time to Nursing Home Placement among Patients with Dementia

Tools:

Journal Title:

JAMA Network Open

Volume:

Volume 4, Number 1

Publisher:

, Pages e2034745-e2034745

Type of Work:

Article | Final Publisher PDF

Abstract:

This cohort study assesses the utility of restricted mean survival time as a method for quantifying time to nursing home placement among patients with dementia.

Copyright information:

2021 Kim DH et al. JAMA Network Open.

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Export to EndNote